Small molecule induction of MSH2-dependent cell death suggests a vital role of mismatch repair proteins in cell death

DNA Repair

Volumn 8, Issue 1, 2009, Pages 103-113

  Vasilyeva, Aksana ^a   Clodfelter, Jill E ^a   Rector, Brian ^a   Hollis, Thomas ^a   Scarpinato, Karin D ^a   Salsbury Jr , Freddie R ^b  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b WAKE FOREST UNIVERSITY   (United States)

Author keywords

Cell death; Computational modeling; Death conformation; MutS homolog; Small molecule

Indexed keywords

PROTEIN MSH2; RESERPINE;

APOPTOSIS; ARTICLE; CELL DEATH; CELL SURVIVAL; CONFORMATIONAL TRANSITION; HUMAN; HUMAN CELL; MOLECULAR DOCKING; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN INDUCTION;

CASPASE 3; CELL DEATH; CISPLATIN; COMPUTER SIMULATION; DNA MISMATCH REPAIR; DNA-BINDING PROTEINS; HUMANS; MODELS, MOLECULAR; MUTS HOMOLOG 2 PROTEIN; PROTEIN CONFORMATION; RESERPINE; SACCHAROMYCES CEREVISIAE PROTEINS;

EID: 56549107652     PISSN: 15687864     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dnarep.2008.09.008     Document Type: Article

References (26)

1. Kunkel T.A., and Erie D.A. DNA mismatch repair. Annu. Rev. Biochem. 74 (2005) 681-710
2. Li G.M. Mechanisms and functions of DNA mismatch repair. Cell Res. 18 (2008) 85-98
3. Drotschmann K., Topping R.P., Clodfelter J.E., and Salsbury F.R. Mutations in the nucleotide-binding motif of MutS homologs uncouple cell death from cell survival. DNA Repair 3 (2004) 729-742
4. Irving J.A., and Hall A.G. Mismatch repair defects as a cause of resistance to cytotoxic drugs. Expert Rev. Anticancer Ther. 1 (2001) 149-158
5. Fedier A., and Fink D. Mutations in DNA mismatch repair genes: implications for DNA damage signaling and drug sensitivity. Int. J. Oncol. 24 (2004) 1039-1104
6. Jiricny J. The multifaceted mismatch-repair system. Nat. Rev. Mol. Cell Biol. 7 (2006) 335-346
7. Salsbury F.R., Clodfelter J.E., Gentry M.B., Hollis T., and Scarpinato K.D. The molecular mechanism of DNA damage recognition by MutS homologs and its consequences for cell death response. Nucleic Acids Res. 34 (2006) 2173-2185
8. Lin D.P., Wang Y., Scherer S.J., Clark A.B., Yang K., Avdievich E., Jin B., Werling U., Parris T., Kurihara N., Umar A., Kucherlapati R., Lipkin M., Kunkel T.A., and Edelmann W. An Msh2 point mutation uncouples DNA mismatch repair and apoptosis. Cancer Res. 15 (2004) 517-522
9. Roos W.P., and Kaina B. DNA damage-induced cell death by apoptosis. Trends Mol. Med. 12 (2006) 440-450
10. Lerner M.G., Bowman A.L., and Carlson H.A. Incorporating dynamics in E. coli dihydrofolate reductase enhances structure-based drug discovery. J. Chem. Info. Model. 47 (2007) 2358-2365
11. Bowman A.L., Lerner M.G., and Carlson H.A. Protein flexibility and species specificity in structure-based drug discovery: dihydrofolate reductase as a test system. J. Am. Chem. Soc. 129 (2007) 3634-3640
12. Gunasekaran K., Ma B.Y., and Nussinov R. Is allostery an intrinsic property of all dynamic proteins?. Proteins: Struct. Funct. Bioinf. 57 (2004) 433-443
13. Lamers M.H., Perrakis A., Enzlin J.H., Winterwerp H.H.K., de Wind N.M., and Sixma T.K. The crystal structure of DNA mismatch repair protein MutS binding to a GT mismatch. Nature 407 (2000) 711-717
14. Brooks B.R., Bruccoleri R.D., Olafson B.D., States D.J., Swaminathan S., and Karplus M. CHARMM: a program for macromolecular energy, minimization and dynamics calculations. J. Comput. Chem. 4 (1983) 187-217
15. Humphrey W., Dalke A., and Schulten K. VMD-visual molecular dynamics. J. Mol. Graphics 14 (1996) 33-38
16. MacKerell A.D., Bashford D., Bellott M., Dunbrack R.L., Evanseck J.D., Field M.J., Fischer S., Gao J., Guo H., Ha S., Joseph-McCarthy D., Kuchnir L., Kuczera K., Lau F.T.K., Mattos C., Michnick S., Ngo T., Nguyen D.T., Prodhom B., Reiher III W.E., Roux B., Schlenkrich M., Smith J.C., Stote R., Straub J., Watanabe M., Wiorkiewicz-Kuczera J., Yin D., and Karplus M. All-atom empirical potential for molecular modeling and dynamics studies of proteins and nucleic acids. J. Phys. Chem. 102 (1998) 3586-3616
17. Scheef E.D., Briggs J.M., and Howell S.B. Molecular modeling of the intrastrand guanine-guanine DNA adducts produced by cisplatin and oxaliplatin. Mol. Pharm. 56 (1999) 633-643
18. Kale L., Skeel R., Bhandarkar M., Brunner R., Gursoy A., Krawetz N., Phillips J., Shinozaki A., Varadarajan K., and Schulten K. NAMD2: greater scalability for parallel molecular dynamics. J. Comp. Phys. 151 (1999) 283-312
19. Morris G.M., Goodsell D.S., Halliday R.S., Huey R., Hart W.E., Belew R.K., and Olson A.J. Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J. Comp. Chem. 19 (1998) 1639-1662
20. Koshiura R., Miyamoto K., and Sanae F. Combination antitumor effect with central nervous system depressants on rat ascites haptomas. Gann. 71 (1980) 45-51
21. Yan T., Schupp J.E., Hwang H.S., Wagner M.W., Berry S.E., Strickfaden S., Veigl M.L., Sedwick W.D., Boothman D.A., and Kinsella T.J. Loss of DNA mismatch repair imparts defective cdc2 signaling and G(2) arrest responses without altering survival after ionizing radiation. Cancer Res. 61 (2001) 8290-8297
22. Warren J.J., Pohlhaus T.J., Changela A., Iyer R.R., Modrich P.L., and Beese L.S. Structure of the human MutS alpha DNA lesion recognition complex. Mol. Cell. 26 (2007) 579-592
23. Lina B.A.R., Woutersen R.A., Bruijntjes J.P., van Benthem J., van den Berg J.A.H., Monbaliu J., Thoolen B.J.J.M., Beems R.B., and van Kreijl C.F. Evaluation of the Xpa-deficient transgenic mouse model for short-term carcinogenicity testing: 9-month studies with Haloperidol, Reserpine, Phenacetin and D-Mannitol. Toxicol. Pathol. 32 (2004) 192-201
24. von Poser G., Andrade H.H., da Silva K.V., Henriques A.T., and Henriques J.A. Genotoxic, mutagenic and recombinogenic effects of rauwolfia alkaloids. Mutat. Res. 232 (1990) 37-43
25. Kevekordes S., Mersch-Sundermann V., Burghaus C.M., Spielberger J., Schmeiser H.H., Arit V.M., and Dunkelberg H. SOS induction of selected naturally occurring substances in Escherichia coli (SOS chromotest). Mutat. Res. 445 (1999) 81-91
26. Martin L.P., Hamilton T.C., and Schilder R.J. Platinum resistance: the role of DNA repair pathways. Clin. Cancer Res. 14 (2008) 1291-1295